Add to ORKGOn June 8, 2018 the federal Eighth Circuit Court of Appeals announced its decision concerning Arkansas\u27 attempt to regulate perceived unfair payment practices of pharmacy benefit managers (PBMs) in the case Pharmaceutical Care Management Association v. Rutledge.1 Because pharmacies across the country face similar problems, and this ruling may influence other federal appellate courts, review and discussion is useful for the purpose of making strategic decisions
Problem solving courts, including Drug Court, were established to address substance abuse while prov...
Between $3 and $4 billion in Medicare hospital reimbursements hang in the balance due to a case that...
the U.S. Supreme Court, reversing a decision of the U.S. Court of Appeals for the Seventh Circuit, h...
On June 8, 2018 the federal Eighth Circuit Court of Appeals announced its decision concerning Arkans...
On May 19, 2003, the Supreme Court in Pharmaceutical Research and Manufacturers of America v. Walsh ...
News & Issues piece on a recent ruling by the First U.S. Circuit Court of Appeals in Boston, liftin...
New piece reporting that Pharmaceutical Research and Manufacturers of America (PhRMA) filed a petit...
Pharmacy benefit management (PBM) companies are the middlemen of the pharmaceutical industry, design...
Business Maine: Central & Western piece briefly reporting that Pharmaceutical Care Management has ...
The U.S. Supreme Court’s important ruling in Mutual Pharmaceutical Co., Inc. v. Bartlett concerns wh...
In Aetna Health Inc. v. Davila, the United States Supreme Court revisited the question of whether th...
Under the Federal 340B Program, hospitals and eligible health care clinics that serve low income or ...
In American Hospital Association v. NLRB the United States Supreme Court reversed a lower court ruli...
The article presents information on the pharmaceutical companies manufacturing brand-name drugs and ...
When Maine’s Superintendent of Insurance told the state’s largest health insurer that it could not p...
Problem solving courts, including Drug Court, were established to address substance abuse while prov...
Between $3 and $4 billion in Medicare hospital reimbursements hang in the balance due to a case that...
the U.S. Supreme Court, reversing a decision of the U.S. Court of Appeals for the Seventh Circuit, h...
On June 8, 2018 the federal Eighth Circuit Court of Appeals announced its decision concerning Arkans...
On May 19, 2003, the Supreme Court in Pharmaceutical Research and Manufacturers of America v. Walsh ...
News & Issues piece on a recent ruling by the First U.S. Circuit Court of Appeals in Boston, liftin...
New piece reporting that Pharmaceutical Research and Manufacturers of America (PhRMA) filed a petit...
Pharmacy benefit management (PBM) companies are the middlemen of the pharmaceutical industry, design...
Business Maine: Central & Western piece briefly reporting that Pharmaceutical Care Management has ...
The U.S. Supreme Court’s important ruling in Mutual Pharmaceutical Co., Inc. v. Bartlett concerns wh...
In Aetna Health Inc. v. Davila, the United States Supreme Court revisited the question of whether th...
Under the Federal 340B Program, hospitals and eligible health care clinics that serve low income or ...
In American Hospital Association v. NLRB the United States Supreme Court reversed a lower court ruli...
The article presents information on the pharmaceutical companies manufacturing brand-name drugs and ...
When Maine’s Superintendent of Insurance told the state’s largest health insurer that it could not p...
Problem solving courts, including Drug Court, were established to address substance abuse while prov...
Between $3 and $4 billion in Medicare hospital reimbursements hang in the balance due to a case that...
the U.S. Supreme Court, reversing a decision of the U.S. Court of Appeals for the Seventh Circuit, h...